Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 365

1.

CMR Guidance for Recanalization of Coronary Chronic Total Occlusion.

Bucciarelli-Ducci C, Auger D, Di Mario C, Locca D, Petryka J, O'Hanlon R, Grasso A, Wright C, Symmonds K, Wage R, Asimacopoulos E, Del Furia F, Lyne JC, Gatehouse PD, Fox KM, Pennell DJ.

JACC Cardiovasc Imaging. 2016 Apr 6. pii: S1936-878X(16)30010-9. doi: 10.1016/j.jcmg.2015.10.025. [Epub ahead of print]

PMID:
27085432
2.

Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model.

Oemrawsingh RM, Akkerhuis KM, Van Vark LC, Redekop WK, Rudez G, Remme WJ, Bertrand ME, Fox KM, Ferrari R, Danser AH, de Maat M, Simoons ML, Brugts JJ, Boersma E; PERGENE investigators.

J Am Heart Assoc. 2016 Mar 28;4(3):e002688. doi: 10.1161/JAHA.115.002688.

3.

Paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients With Recent Ischemic Stroke.

Gonzalez-Valcarcel J, Sissani L, Labreuche J, Bousser MG, Chamorro A, Fisher M, Ford I, Fox KM, Hennerici MG, Mattle HP, Rothwell PM, Steg PG, Vicaut E, Amarenco P; PERFORM Investigators.

Stroke. 2016 Apr;47(4):1045-52. doi: 10.1161/STROKEAHA.115.012091. Epub 2016 Mar 15.

PMID:
26979864
4.

The chemical biology of Cu(II) complexes with imidazole or thiazole containing ligands: Synthesis, crystal structures and comparative biological activity.

Lewis A, McDonald M, Scharbach S, Hamaway S, Plooster M, Peters K, Fox KM, Cassimeris L, Tanski JM, Tyler LA.

J Inorg Biochem. 2016 Apr;157:52-61. doi: 10.1016/j.jinorgbio.2016.01.014. Epub 2016 Jan 11.

PMID:
26828284
5.

Lipid-lowering treatment patterns in patients with new cardiovascular events - estimates from population-based register data in Sweden.

Hallberg S, Banefelt J, Fox KM, Mesterton J, Johansson G, Levin LÅ, Sobocki P, Gandra SR.

Int J Clin Pract. 2016 Mar;70(3):222-8. doi: 10.1111/ijcp.12769. Epub 2016 Jan 22.

6.

Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort study.

Fox KM, Wang L, Gandra SR, Quek RG, Li L, Baser O.

BMC Cardiovasc Disord. 2016 Jan 14;16:13. doi: 10.1186/s12872-016-0190-x.

7.

A US Claims-Based Analysis of Real-World Lipid-Lowering Treatment Patterns in Patients With High Cardiovascular Disease Risk or a Previous Coronary Event.

Quek RG, Fox KM, Wang L, Li L, Gandra SR, Wong ND.

Am J Cardiol. 2016 Feb 15;117(4):495-500. doi: 10.1016/j.amjcard.2015.11.035. Epub 2015 Dec 2.

8.
9.

Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden.

Banefelt J, Hallberg S, Fox KM, Mesterton J, Paoli CJ, Johansson G, Levin LÅ, Sobocki P, Gandra SR.

Eur J Health Econ. 2015 Nov 25. [Epub ahead of print]

PMID:
26607457
10.

Long-Term Increased Inpatient and Outpatient Visits Associated with Cardiovascular Events: a Large United States Real World Study.

Fox KM, Wang L, Quek RG, Gandra SR, Li L, Baser O.

Value Health. 2015 Nov;18(7):A377-8. doi: 10.1016/j.jval.2015.09.792. Epub 2015 Oct 20. No abstract available.

PMID:
26532132
11.

Lipid-lowering treatment patterns among patients with type 2 diabetes mellitus with high cardiovascular disease risk.

Quek RG, Fox KM, Wang L, Li L, Gandra SR, Wong ND.

BMJ Open Diabetes Res Care. 2015 Sep 23;3(1):e000132. doi: 10.1136/bmjdrc-2015-000132. eCollection 2015.

12.

Burden of First and Recurrent Cardiovascular Events Among Patients With Hyperlipidemia.

Punekar RS, Fox KM, Richhariya A, Fisher MD, Cziraky M, Gandra SR, Toth PP.

Clin Cardiol. 2015 Aug;38(8):483-91. doi: 10.1002/clc.22428. Epub 2015 Jun 23.

13.

Healthcare costs associated with cardiovascular events in patients with hyperlipidemia or prior cardiovascular events: estimates from Swedish population-based register data.

Hallberg S, Gandra SR, Fox KM, Mesterton J, Banefelt J, Johansson G, Levin LÅ, Sobocki P.

Eur J Health Econ. 2015 Jun 16. [Epub ahead of print]

PMID:
26077550
14.

The role of heart rate may differ according to pathophysiological setting: from SHIFT to SIGNIFY.

Ferrari R, Fox KM.

Eur Heart J. 2015 Aug 14;36(31):2042-2046. Epub 2015 Apr 28. No abstract available.

PMID:
25920402
15.

Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry.

Fauchier L, Greenlaw N, Ferrari R, Ford I, Fox KM, Tardif JC, Tendera M, Steg PG; CLARIFY Investigators.

PLoS One. 2015 Apr 27;10(4):e0125164. doi: 10.1371/journal.pone.0125164. eCollection 2015.

16.

Heart rate and B-blockade in stable coronary artery disease in Greece.

Sbarouni E, Voudris V, Georgiadou P, Hamilos M, Steg G, Fox KM, Greenlaw N, Vardas PE; Greek CLARIFY investigators.

Hellenic J Cardiol. 2015 Mar-Apr;56(2):112-7.

17.

Hematologic and biochemical reference intervals for adult Friesian horses from North America.

Sample SH, Fox KM, Wunn D, Roth E, Friedrichs KR.

Vet Clin Pathol. 2015 Jun;44(2):194-9. doi: 10.1111/vcp.12248. Epub 2015 Feb 26.

PMID:
25727137
18.

Cardiovascular event rates and healthcare resource utilisation among high-risk adults with type 2 diabetes mellitus in a large population-based study.

Fox KM, Wu Y, Kim J, Grandy S.

Int J Clin Pract. 2015 Feb;69(2):218-27. doi: 10.1111/ijcp.12530.

PMID:
25627336
19.

Serial changes in high-sensitivity cardiac troponin, N-terminal pro-B-type natriuretic peptide, and heart fatty acid binding protein during exercise echocardiography in patients with suspected angina pectoris and normal resting left ventricular function.

de Silva R, Tsujioka H, Gaze D, Banya WA, Shah BN, Zoppelaro G, Hersey J, Gonzalez AM, Collins P, Collinson PO, Senior R, Fox KM.

Clin Chem. 2015 Mar;61(3):554-6. doi: 10.1373/clinchem.2014.228536. Epub 2015 Jan 16. No abstract available.

20.

Clinical presentation and management of stable coronary artery disease: insights from the international prospective CLARIFY registry - results from the Greek national cohort.

Sbarouni E, Voudris V, Georgiadou P, Hamilos M, Steg PG, Fox KM, Greenlaw N, Ferrari R, Vardas PE.

Hellenic J Cardiol. 2014 Nov-Dec;55(6):442-7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk